| Old Articles: <Older 37161-37170 Newer> |
|---|
 |
The Motley Fool
July 7, 2009
Dan Caplinger |
So Much for This Shattered Crystal Ball To celebrate the midpoint of 2009, let's look back at the contest we started at the beginning of the year and check in on what readers picked to be the year's best stocks.   |
The Motley Fool
July 7, 2009
Chuck Saletta |
Don't Even Think About Investing Until ... ... you have the rest of your financial life in order. However, in spite of the recent market meltdown, just take a look at how strongly these titans have performed over the past 25 years. |
The Motley Fool
July 7, 2009
Selena Maranjian |
Don't Get Squashed by Carbon Footprints Pretty soon it may matter how carbon-friendly your investments are for their financial performance. |
The Motley Fool
July 7, 2009
Rick Aristotle Munarriz |
eBay's Ready to Party Like It's 1999 Analysts at Jefferies & Co. and Collins Stewart believe that the company's struggling auction platform is finally turning the corner. |
The Motley Fool
July 7, 2009 |
Today's 5-Star Movers Stocks looking up are united Health Group, Cathay Pacific Airlines, and Internet Gold Golden Lines among others. |
The Motley Fool
July 7, 2009
Todd Wenning |
The Worst Stocks to Buy Today Since March 9, International Paper shares have gained 237% and MGM Mirage 154%. These are just two examples of the recent "dash to trash" in this market rally. |
The Motley Fool
July 7, 2009
Rick Aristotle Munarriz |
A Million Questions for Sirius XM Sirius XM Radio has 1 million app downloads. What will it do with them? |
The Motley Fool
July 6, 2009
Rick Aristotle Munarriz |
4 Dividend Stocks Showing You the Money These companies recently raised their dividends: General Mills... PetSmart... PepsiCo... Johnson & Johnson... |
The Motley Fool
July 6, 2009
Anders Bylund |
Fickle EMC Romances Data Domain Yet Again EMC's new offer for Data Domain is materially more tempting than the old one, kicking the all-cash consideration up from $30 per share to $33.50 per share. |
The Motley Fool
July 6, 2009
Brian Orelli |
Lilly Shows Us How It's Done The company announces that the Food and Drug Administration had expanded the approval of its cancer drug, Alimta, to include maintenance therapy for nonsquamous, non-small cell lung cancer. |
| <Older 37161-37170 Newer> Return to current articles. |
